A new study provides a comprehensive overview of the current state of metabolomics research in arterial stiffness on a less ...

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

Sanofi SNY announced that the FDA has granted orphan drug designation to its investigational BTK inhibitor, rilzabrutinib, ...

Researchers at Emory University have provided compelling evidence supporting the existence of an inflammatory subtype of ...

Track frequency, appearance, and accompanying symptoms like lethargy or appetite loss. Dietary changes, infections, and ...

For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers in blood, characterized by high-sensitivity C-reactive protein, despite ...